Status:
TERMINATED
The Effect of Home-based Rehabilitation Program After COVID-19 Infection
Lead Sponsor:
National Taiwan University Hospital
Conditions:
COVID-19
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
To follow up the cardiopulmonary function after coronavirus disease 2019 (CoVID-19) infection and compare the effect of a 12-week home-based cardiopulmonary with or without add-on remote rehabilitatio...
Detailed Description
The investigators will recruit the patients post-CoVID infection for a cardiopulmonary function evaluation and a home-based rehabilitation program. The investigators hypothesize that an add-on remote ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- ≥ 20 years of age.
- COVID-19 survivor after de-isolation at post-acute stage about to be discharged or already at outpatient follow-up who still have symptoms or exercise intolerance.
- Exclusion criteria:
- Unable to cooperate with rehabilitation or evaluation.
- Dependent in basic activities of living before infection (Premorbid Barthel index \<80).
- End stage patient, with life expectancy less than 1 year.
- Having contraindications for exercise according to the evaluation of a physician.
Exclusion
Key Trial Info
Start Date :
July 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 17 2025
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT05317975
Start Date
July 15 2021
End Date
February 17 2025
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100